PremiumThe FlyOpthea downgraded to Neutral from Buy at H.C. Wainwright CoreWeave initiated, Carvana upgraded: Wall Street’s top analyst calls Hold Rating Issued for Opthea Limited Amid Uncertainty Following Phase 3 Trial Failure PremiumRatingsOpthea Limited: Promising Clinical Trials and Strong Financial Position Support Buy Rating with $13 Target Opthea announces Phase 2b Wet AMD publication Opthea Limited Reports Increased Losses Amid Clinical Advancements PremiumRatingsOptimistic Outlook and Buy Rating for Opthea Limited Amid Promising Phase 3 Trials and Strong Financial Position Opthea completes COAST final week 52 patient visit Opthea Completes Key Phase 3 Trial Milestone in Wet AMD Treatment 
